financetom
Business
financetom
/
Business
/
Troubled casino firm Star names new CEO amid regulator enquiries, management exodus
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Troubled casino firm Star names new CEO amid regulator enquiries, management exodus
Jun 25, 2024 9:06 PM

(Reuters) -Australia's Star Entertainment has appointed Steve McCann as its group CEO and managing director to lead the embattled casino operator out of a regulator inquiry into its Sydney operations that had triggered a management exodus in recent months.

The embattled casino operator said on Wednesday that McCann, who previously served as top boss at Australian casino firm Crown Resorts, now owned by Blackstone, will join the firm on July 8.

Star said that McCann will be expected to navigate the firm out of a second inquiry into the firm's suitability to manage its Sydney casino operations while working with a new management team following a slew of high-level departures.

The casino operator's shares were trading 2.2% higher as of 0239 GMT. They were up as much as 3.2% earlier in the day.

"I look forward to joining The Star at this critical time," McCann said in a statement.

"I recognise that there are many complex issues and challenges for the company to address."

His appointment follows the departure of former CEO Robbie Cooke and finance boss Christina Katsibouba in March this year, and nearly two years after longstanding top boss Matt Bekier resigned, amid an investigation into Star over breaches of anti-money laundering and counter-terrorism laws.

"A change of CEO will do very little to change the challenging headwinds Star is facing," Brad Smoling, managing director at Smoling Stockbroking, said.

McCann, who has also held top executive positions at real estate firm Lendlease, will be paid A$2.5 million annually and a A$2.5 million sign-on bonus, among other provisions like performance rights, Star said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: W. P. Carey President John Park to Step Down in September
--Street Color: W. P. Carey President John Park to Step Down in September
Jul 10, 2024
07:48 AM EDT, 07/10/2024 (MT Newswires) -- Price: 54.90, Change: +0.05, Percent Change: +0.09 ...
Walker & Dunlop Arranges $148 Million Refinancing for New York City Building
Walker & Dunlop Arranges $148 Million Refinancing for New York City Building
Jul 10, 2024
07:44 AM EDT, 07/10/2024 (MT Newswires) -- Walker & Dunlop ( WD ) said Wednesday it has arranged $148 million in loan proceeds for Lam Group and Exact Capital to refinance The Victoria, a 30-story multi-tower project in Harlem, New York City. The loan, which will be used for the building's ongoing operations and future enhancements, was secured from Aareal...
Top Premarket Gainers
Top Premarket Gainers
Jul 10, 2024
07:48 AM EDT, 07/10/2024 (MT Newswires) -- NaaS Technology ( NAAS ) stock was up over 79% in recent Wednesday premarket activity, adding to Tuesday's 68% gain. Ampco-Pittsburgh ( AP ) shares were 49% higher after the company said overnight its Union Electric Steel unit was selected to provide the initial provisioning of rolls for two new rolling mill projects...
Amylyx Pharmaceuticals Acquires Avexitide From Eiger BioPharmaceuticals for $35 Million
Amylyx Pharmaceuticals Acquires Avexitide From Eiger BioPharmaceuticals for $35 Million
Jul 10, 2024
07:46 AM EDT, 07/10/2024 (MT Newswires) -- Amylyx Pharmaceuticals ( AMLX ) said Wednesday that it has acquired avexitide for the potential treatment of hyperinsulinemic hypoglycemia from Eiger BioPharmaceuticals for $35.1 million. Amylyx said it has also assumed certain contractual obligations from Eiger, including a 3% royalty on future sales of avexitide in post-bariatric hypoglycemia, if approved, to certain academic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved